#AVTX Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
https://www.stocktitan.net/news/AVTX/avalo-therapeutics-announces-completion-of-enrollment-in-phase-2-x0enghxd11si.html
https://www.stocktitan.net/news/AVTX/avalo-therapeutics-announces-completion-of-enrollment-in-phase-2-x0enghxd11si.html
Avalo Therapeutics Announces Completion of Enrollment in Phase 2 LOTUS Trial of AVTX-009 for the Treatment of Hidradenitis Suppurativa
Avalo Therapeutics (Nasdaq: AVTX) announced completion of enrollment in its Phase 2 LOTUS trial of AVTX-009 for adults with hidradenitis suppurativa (HS).The trial exceeded its target of 222 patients with approximately 250 patients enrolled. LOTUS is a randomized, double-blind, placebo-controlled Phase 2 study (1:1:1) testing two AVTX-009 dose regimens versus placebo during a 16-week treatment phase. The primary endpoint is the proportion achieving HiSCR75 at Week 16. Secondary measures include HiSCR50/90, IHS4, draining fistula count, AN count, and PGA Skin Pain reductions. Topline data are expected in mid-2026. Trial identifiers: NCT06603077 and www.lotustrial.com.
www.stocktitan.net
October 29, 2025 at 11:00 AM
Everybody can reply
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket Shares of Merus NV (NASDAQ: MRUS ) rose sharply in today's pre-market trading . Genmab announced plans to acquire...
#AVTX #BIAF #CGC #CLLS #CYCU #ENTA #ENTA #EPOW #JFB #LRMR #MLTX
Origin | Interest | Match
#AVTX #BIAF #CGC #CLLS #CYCU #ENTA #ENTA #EPOW #JFB #LRMR #MLTX
Origin | Interest | Match
Why Merus Shares Are Trading Higher By 38%; Here Are 20 Stocks Moving Premarket - bioAffinity Technologies (NASDAQ:BIAF), Avalo Therapeutics (NASDAQ:AVTX)
Shares of Merus NV (NASDAQ: MRUS) rose sharply in today's pre-market trading. Genmab announced plans to acquire Merus for $8 billion in all-cash deal adding breakthrough therapy Petosemtamab to its late-stage pipeline.
www.benzinga.com
September 29, 2025 at 10:41 AM
Everybody can reply
$AVTX +15.8% [H.C. Wainwright increased Avalo Therapeutics' price target to $25 and maintains a Buy rating.]
September 17, 2025 at 4:04 PM
Everybody can reply
$IMNM $AVTX $CHA $DLB $DUOL $EPAC $EOSE $ESAB $FNMA $HNGE $KRMN $LECO $LION $OMDA $QXO $RVMD $STRZ $TKO $TWLO $WAY $PSKY $PHR $STT $TJX $PATH $BK $NTRS $CIEN $CELH $LULU $GIII $IOT $AVGO $PATH $DAVA -- THE WSJ
September 5, 2025 at 1:50 PM
Everybody can reply
$AVTX $BBOT $CLYM $EXOD $ICUI $MYRG $PH $RVMD $SKYE $LQDA $EVLV $MBX -- THE WSJ
August 15, 2025 at 1:28 PM
Everybody can reply
#AVTX Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates
https://www.stocktitan.net/news/AVTX/avalo-reports-second-quarter-2025-financial-results-and-recent-hfoi40hc9ai4.html
https://www.stocktitan.net/news/AVTX/avalo-reports-second-quarter-2025-financial-results-and-recent-hfoi40hc9ai4.html
Avalo Reports Second Quarter 2025 Financial Results and Recent Business Updates
Avalo Therapeutics (Nasdaq: AVTX), a clinical-stage biotech company focused on IL-1β-based treatments, reported Q2 2025 financial results and business updates. The company's Phase 2 LOTUS trial for hidradenitis suppurativa (HS) has enrolled over 75% of planned patients, with topline data expected mid-2026.Financial highlights include $113.3 million in cash and short-term investments as of June 30, 2025, providing runway into 2028. Q2 2025 showed a net loss of $20.8 million ($1.92 per share), compared to net income of $98.5 million in Q2 2024. R&D expenses increased by $9.5 million to $14.1 million, primarily due to LOTUS trial costs.The company strengthened its leadership by appointing Rita Jain, M.D. to the Board of Directors, bringing valuable experience in clinical development and regulatory strategy.
www.stocktitan.net
August 7, 2025 at 11:00 AM
Everybody can reply
The rise of anti-gender movements threaten democratic values in the Western Balkans.
Watch #ReThinkCEE fellow Angel Dimitrievski,Adriana Zaharijevic(Uni Belgrade), Irena Cvetkovic(Coalition Margins) & @danielhegedus.bsky.social @gmfus.bsky.social discuss their impact.
www.youtube.com/watch?v=AVtx...
Watch #ReThinkCEE fellow Angel Dimitrievski,Adriana Zaharijevic(Uni Belgrade), Irena Cvetkovic(Coalition Margins) & @danielhegedus.bsky.social @gmfus.bsky.social discuss their impact.
www.youtube.com/watch?v=AVtx...
Battling the Backlash: The Future of Gender Equality in the Western Balkans
YouTube video by The German Marshall Fund of the United States
www.youtube.com
July 11, 2025 at 1:48 PM
Everybody can reply
2 reposts
2 likes
$ABEO, $AQST, $AVTX, $DYN, $HRMY, $MDWD, $PYPD, $PRAX, $SENS, $SNSE, $TARS -- THE WSJ
June 2, 2025 at 2:04 PM
Everybody can reply
$CTMX priced a $100 million public offering and reported positive interim Phase 1 data for EpCAM-targeting CX-2051 in advanced CRC, with a 28% confirmed response rate overall
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/cy...
$CASI $VALN $ABEO $AVTX $EWTX $TLSA
See More Pre-market Movers 👇
www.biopharmcatalyst.com/news/2025/cy...
$CASI $VALN $ABEO $AVTX $EWTX $TLSA
May 12, 2025 at 12:27 PM
Everybody can reply
#AVTX Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
https://www.stocktitan.net/news/AVTX/avalo-reports-first-quarter-2025-financial-results-and-recent-ws03uf0gpaqj.html
https://www.stocktitan.net/news/AVTX/avalo-reports-first-quarter-2025-financial-results-and-recent-ws03uf0gpaqj.html
Avalo Reports First Quarter 2025 Financial Results and Recent Business Updates
Avalo Therapeutics (NASDAQ: AVTX) reported its Q1 2025 financial results and business updates. The company ended Q1 with $125 million in cash, providing runway into 2027 with potential extension into 2028. The Phase 2 LOTUS trial for AVTX-009 in hidradenitis suppurativa (HS) is progressing as planned, with topline data expected in 2026.Q1 2025 financial highlights include: net loss of $13.1 million ($1.25 per share), R&D expenses of $9.1 million (up $7.0M YoY), and G&A expenses of $5.5 million (up $2.4M YoY). The company is carefully evaluating the timing of additional development activities beyond LOTUS trial due to current market conditions.
[ "Strong cash position of $125M providing runway into 2027, with potential extension to 2028", "Phase 2 LOTUS trial enrollment progressing on schedule with topline data expected in 2026", "Significant reduction in net loss to $13.1M in Q1 2025 from $121.3M in Q1 2024"
]
www.stocktitan.net
May 12, 2025 at 11:00 AM
Everybody can reply
52 Weel Highs & Lows
🟢 $BWMN $WHG $TVC $NCLH $NTRS $PHIN $AVTX $DCRE
🔴 $BKN $SSY $GFAI $LFST $MTAL $SBCF $RSVR $KTCC
🟢 $BWMN $WHG $TVC $NCLH $NTRS $PHIN $AVTX $DCRE
🔴 $BKN $SSY $GFAI $LFST $MTAL $SBCF $RSVR $KTCC
April 30, 2025 at 3:00 PM
Everybody can reply
🚨 #Avantium $AVTX announces a €40 million share issuance—more than double our estimate. With a current market cap of just €93 million, the (dilution) impact for investors is significant. But why is this amount so high?
🔍Check my analysis on @iex.nl:
www.iex.nl/Premium/Advi...
🔍Check my analysis on @iex.nl:
www.iex.nl/Premium/Advi...
Avantium financieel met de rug tegen de muur
Bij Avantium hakt de aankondiging van alweer de vijfde emissie in slechts vier jaar er flink in. Vooral de omvang hiervan is zorgelijk.
www.iex.nl
April 2, 2025 at 12:56 PM
Everybody can reply
For #Avantium $AVTX, 2025 is a make-or-break year. The coming quarters will reveal whether the new #FDCA plant can live up to its big promise. Despite two share placements and a major refinancing in 2024, the financial woes are far from over. Shareholders face another tough year.
March 21, 2025 at 12:48 PM
Everybody can reply
#AVTX Avalo Reports 2024 Financial Results and Recent Business Updates
https://www.stocktitan.net/news/AVTX/avalo-reports-2024-financial-results-and-recent-business-l0yxbzqruzg1.html
https://www.stocktitan.net/news/AVTX/avalo-reports-2024-financial-results-and-recent-business-l0yxbzqruzg1.html
Avalo Secures 3-Year Cash Runway with $134.5M, Pushes Forward Phase 2 Trial
Avalo strengthens financial position with $185M placement, extending runway to 2027. Phase 2 LOTUS trial in hidradenitis suppurativa progresses with new strategic leadership.
www.stocktitan.net
March 20, 2025 at 11:00 AM
Everybody can reply
NEWS: ( NASDAQ: #AVTX ) Avalo Therapeutics Appoints Jennifer Riley as Chief Strategy Officer
#StockMarket #News
#StockMarket #News
January 2, 2025 at 4:45 PM
Everybody can reply
Here is the next of several videos related to Lube that you might enjoy. They are a few years old, but COVID really threw a wrench into any forward progress I may have been making... sigh. And yes, that's me!
www.youtube.com/watch?v=AVtX...
www.youtube.com/watch?v=AVtX...
Lube: A Modern Love Story - Music Video - Lube (Theme Song) - Jack Turner
YouTube video by Lube Musical
www.youtube.com
November 16, 2024 at 2:07 AM
Everybody can reply
Here's the trailer, in its original glory, without the Mengsk voice-over they added in the game itself. www.youtube.com/watch?v=aVtX...
Starcraft 2 Trailer HD
YouTube video by neocloak
www.youtube.com
October 14, 2024 at 2:51 AM
Everybody can reply
2 likes
Me preparing to film a video for the first time since April: www.youtube.com/watch?v=aVtX...
Starcraft 2 Trailer HD
YouTube video by neocloak
www.youtube.com
September 26, 2024 at 3:38 PM
Everybody can reply
1 reposts
8 likes
My name is Wouter Scherphof and I endorse this message. youtu.be/avtX-CWmVG8?...
Varoufakis: Europeans, Not Hamas, Are Criminals
Yianis Varoufakis told red. media “those who try very hard to extract a condemnation of the attack by Hamas” from him or his movement DiEM25 will “never get ...
youtu.be
October 10, 2023 at 10:54 AM
Everybody can reply
and yanis verweisen ☝️🤷
www.youtube.com/watch?v=avtX...
www.youtube.com/watch?v=avtX...
Varoufakis: Europeans, Not Hamas, Are Criminals
Yianis Varoufakis told red. media “those who try very hard to extract a condemnation of the attack by Hamas” from him or his movement DiEM25 will “never get ...
www.youtube.com
October 9, 2023 at 4:14 PM
Everybody can reply
1 likes
Gonna be another $AVTX day?? 📈
September 14, 2023 at 8:05 AM
Everybody can reply
Not supposed to be trading on holiday but was playing $AVTX yesterday. Luckily i kept some overnight.. but small in case i got distracted 📈.. maybe it will do 100% again tomorrow?
September 13, 2023 at 8:21 PM
Everybody can reply
1 likes